Celadon Pharmaceuticals PLC

CEL.UK

$0.77

Closing

▲6.25%

1D

▼-48.26%

YTD

CEL

BBG00M643743

Market cap

$50.99M

52 week high

$2.00

52 week low

$0.71

Volume

42,742

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$50.99M

Analysts' Rating

BUY

Price Target (Mean)

Unable to collect data for some field(s).

Total Analysts

0

P/E

Operating Margin

0.00%

Beta

-0.06

Revenue Growth (Annual)

-

52 week high

$2.00

52 week low

$0.71

Div. Yield

%

EPS Annual Growth

0.00

Company Profile

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism. The Company’s facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company’s subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.